Drug Database
Back to search

Poland· PL-100061814

Solpadeine

A paracetamol, kombinationen, exkl. psycholeptika product containing paracetamolum + coffeinum + codeini phosphas, registered in Poland by Perrigo Poland Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC N02BE51

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSolpadeineATCN02BE51REGISTER NO.PL-100061814PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about paracetamolum + coffeinum + codeini phosphasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Paracetamol, kombinationen, exkl. psycholeptika is registered in 13 of 19 countries.

Countries holding a registration under ATC N02BE51 (paracetamol, kombinationen, exkl. psycholeptika), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search paracetamol, kombinationen, exkl. psycholeptika products by name

Paracetamol, kombinationen, exkl. psycholeptika · ATC N02BE51

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Paracetamolum + Coffeinum + Codeini phosphas
Manufacturer
Perrigo Poland Sp. z o.o.
Country
Poland (PL)
ATC code
N02BE51
ATC class
Paracetamol, Kombinationen, exkl. Psycholeptika
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990343522
  • gtin
    05909990343515
  • gtin
    05909991204129
  • gtin
    05907734710852

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for paracetamol, kombinationen, exkl. psycholeptika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check paracetamol, kombinationen, exkl. psycholeptika against other medicinesHow interaction checks work

Paracetamol, kombinationen, exkl. psycholeptika · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Paracetamol, kombinationen, exkl. psycholeptika in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paracetamol, kombinationen, exkl. psycholeptika products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Bulgaria · Солпадеин
  • Cyprus · Lonarid N, Solpadeine
  • Germany · Azur Compositum
  • Estonia · Solpadeine, Solpadeine Soluble
  • Spain · Analgilasa
  • France · Paracetamol / Cafeine / Codeine Biogaran, Paracetamol/Cafeine/Codeine Arrow
  • United Kingdom (Northern Ireland) · Co-Codamol Plus, Codasolve
  • Greece · Lonarid N
  • Ireland · Maxeeze, Paracetamol/Codeine Phosphate Hemihydrate/Caffeine Accord
  • Lithuania · Solpadeine
  • Latvia · Solpadeine, Solpadeine Soluble
  • Malta · Paracetamol/Caffeine/Codeine Phosphate Frilab, Solpadeine
  • Netherlands · Paracetamol/Codeïnefosfaat/Coffeïne Accord
  • Romania · Codamin P, N – Calmant Iii
  • Slovakia · Cetafen Rapid, Panadol Ultra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1ccba28-b71b-4568-8d3b-7a91e63cc519
GET /v1/drugs/c1ccba28-b71b-4568-8d3b-7a91e63cc519?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki musujące",
  "source": "urpl",
  "strength": "500 mg + 30 mg + 8 mg",
  "packaging": "05909990343522 ¦ Rp ¦ Skasowane ¦ 9129\n24 tabl.\n05909990343515 ¦ OTC ¦ 62752\n12 tabl.\n05909991204129 ¦ OTC ¦ Skasowane ¦ 106103\n24 tabl.\n05907734710852 ¦ OTC ¦ 126602\n24 tabl.",
  "substance": "Paracetamolum 500 mg + Coffeinum 30 mg + Codeini phosphas 8 mg",
  "common_name": "Paracetamolum + Coffeinum + Codeini phosphas",
  "pl_product_id": "100061814",
  "pozwolenie_nr": "03435",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about paracetamol, kombinationen, exkl. psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console